Table 1.
Baseline Characteristics
| Control group (N=16) | Exercise group (N=30) | |
|---|---|---|
|
| ||
| Age, years | 53±7 | 53±5 |
| Sex, M/F | 9/7 | 17/13 |
| Body Height, cm | 172±9 | 172±12 |
| Body Weight, kg | 96±14 | 87±16 |
| Body Surface Area (m2) | 2.14±0.20 | 2.03±0.24 |
| Body Mass Index (kg/m2) | 32.2±2.6 | 29.1±4.1 |
| Lean Body Mass, kg | 59±12 | 55±11 |
| Race, n (%) | ||
| White | 9 (56) | 15 (50) |
| Black | 6 (38) | 13 (43) |
| Hispanic | 1 (6) | 2 (7) |
| Risk factors, n (%) | ||
| Hypertension | 11 (69) | 21 (70) |
| Diabetes mellites | 1 (6) | 3 (10) |
| Chronic Kidney Disease | 0 (0) | 0 (0) |
| Smoking | 0 (0) | 1 (3) |
| Medication, n (%) | ||
| ACE inhibitor/ARB | 8 (50) | 19 (63) |
| Ca2+ channel blocker | 1 (6) | 7 (23) |
| Beta blocker | 2 (13) | 4 (13) |
| Diuretics | 5 (31) | 5 (17) |
| 24-hour ABPM sBP, mmHg | 131±13 | 134±15 |
| 24-hour ABPM dBP, mmHg | 77±6 | 81±9 |
| 24-hour ABPM mBP, mmHg | 95±8 | 97±14 |
| 24-hour ABPM HR, bpm | 74±8 | 74±13 |
| RER | 1.15±0.07 | 1.13±0.08 |
| V̇O2 max, L/min | 2.38±0.71 | 2.16±0.56 |
| V̇O2 max, mL/min/kg | 24.5±5.3 | 24.7±5.2 |
M, male; F, Female; ACE inhibitor, angiotensin comberting enzyme inhibitor; ARB, angiotensin II receptor blocker; ABPM, ambulatory blood pressure monitoring; sBP, dBP, and mBP, systolic, diastolic and mean blood pressure; RER, respiratory exchange ratio; V̇O2, oxygen consumption.